Orthopedic Compliance and Audit Readiness
Compliance controls for billing, medical necessity, site of service, modifiers, implants, ancillary ownership, overpayments, payer obligations, and artificial intelligence.
The same record that supports approval and payment must withstand audit. This page integrates federal billing risk, orthopedic-specific exposure, payer obligations, overpayment controls, and artificial-intelligence governance into one operational compliance framework.
Compliance
Compliance in an orthopedic service line is not a separate department's problem. The same documentation that produces an approval produces the audit defense, and the same coding shortcut that accelerates a claim creates the exposure. This section covers the compliance framework, the current federal enforcement environment, the orthopedic-specific risk areas, and the governance obligations that now attach to artificial intelligence.
The legal framework that surrounds orthopedic billing
| Authority | What it reaches | Orthopedic relevance |
|---|---|---|
| False Claims Act | Knowingly presenting, or causing to be presented, a false or fraudulent claim for payment; knowingly making or using a false record material to a false claim; reverse false claims for retained overpayments | Upcoding, unsupported modifiers, services not rendered as documented, and failure to return identified overpayments within the statutory window |
| Civil Monetary Penalties Law | A broad set of prohibited conduct including presenting claims for items or services the person knows or should know are not provided as claimed | Documentation that does not support the level or nature of the service billed |
| Anti-Kickback Statute | Remuneration to induce or reward referrals of items or services payable by a federal health care program | Device and implant vendor relationships, physician-owned distributorships, medical directorships, consulting arrangements, and co-management agreements |
| Physician Self-Referral Law (Stark) | Physician referrals for designated health services to entities with which the physician has a financial relationship, absent an applicable exception | Ancillary services common in orthopedics including imaging, physical therapy, and durable medical equipment; ownership in surgery centers and imaging centers |
| Medicare conditions of payment and coverage | Coverage determinations, documentation requirements, supplier standards, and signature and order requirements | Local Coverage Determination compliance; orthotic and durable medical equipment documentation; physician order and signature integrity |
| State utilization review and prior authorization law | Timelines, criteria transparency, clinical peer review requirements, and increasingly the use of artificial intelligence in adverse determinations | Determines what a practice can demand from a payer and what remedies exist when a payer does not comply |
This summary is provided for orientation only. It is not legal advice, and GoHealthcare does not provide legal advice. Application of any of these authorities to a specific arrangement, claim, or disclosure decision requires qualified healthcare counsel.
The current federal enforcement environment
- Medicare Advantage compliance program guidance. In February 2026 the Department of Health and Human Services Office of Inspector General issued industry segment-specific compliance program guidance for Medicare Advantage, the first update to that guidance since 1999. It applies most directly to plans, but the practical consequence for orthopedic practices is that Medicare Advantage plans are expected to push documentation, coding accuracy, and compliance training obligations downstream to contracted providers as a condition of network participation.
- Modifier scrutiny. Evaluation and management services billed alongside minor surgical procedures remain an active federal review area, with an enforcement history that includes substantial settlements across procedural specialties.
- Risk adjustment and encounter data. Continued federal attention to Medicare Advantage risk adjustment data validation and to coding pattern shifts during model transitions increases the diligence expected of practices that submit diagnosis data to plans.
- Surgical claim accuracy. Federal audit work has previously found high error rates in sampled surgical services, with missing co-surgery and assistant-at-surgery modifiers among the leading defects, which places multi-surgeon orthopedic cases in a documented risk category.
Orthopedic-specific risk areas
| Risk area | Why orthopedics is exposed | Control |
|---|---|---|
| Site-of-service and patient status | The Inpatient Only phase-out removes a protective payment rule and exposes inpatient status to medical review under the two-midnight benchmark | Documented site-of-service determination; explicit inpatient justification note; periodic status audit |
| Implant and device relationships | High-value implants, vendor representatives in the operating room, physician-owned distributorships, and consulting arrangements | Written arrangements reviewed by counsel; fair market value documentation; conflict disclosure; vendor access policy |
| Ancillary service ownership | Imaging, therapy, durable medical equipment, and surgery center ownership are common in orthopedic groups and are squarely within self-referral analysis | Counsel-reviewed structure; documented exception analysis; periodic re-verification as arrangements change |
| Medical necessity for degenerative procedures | Several high-volume orthopedic procedures have contested evidence bases and are explicitly targeted by coverage policy | Criteria-driven documentation; internal pre-submission review on targeted procedures |
| Modifier and unbundling exposure | High density of multiple-procedure, add-on, and multi-surgeon reporting | Modifier decision rules with documentation prerequisites; prospective sampling audit |
| Durable medical equipment and orthoses | Bracing dispensed from the office carries supplier standards, order, and documentation requirements distinct from professional services | Separate policy and audit track for the durable medical equipment function |
| Documentation integrity and templating | Templated notes that carry forward findings create records that contradict the clinical narrative | Copy-forward governance; template audit; attestation discipline |
| Overpayment identification and return | Identified overpayments carry a statutory return obligation and a reverse false claims exposure if retained | Written overpayment escalation pathway with counsel involvement and documented timelines |
Payer-side compliance obligations a practice can invoke
Compliance is not unidirectional. The 2026 regulatory environment created enforceable obligations on payers that orthopedic practices should know how to invoke.
- Decision timeframes. Operational provisions of the CMS Interoperability and Prior Authorization final rule took effect January 1, 2026 for impacted payers, including Medicare Advantage organizations, Medicaid and Children's Health Insurance Program fee-for-service and managed care entities, and qualified health plan issuers on the federally facilitated exchanges. Impacted payers must issue expedited decisions within 72 hours and standard decisions within 7 calendar days.
- Specific denial reasons. Beginning in 2026, impacted payers must provide a specific reason for a denied prior authorization for non-drug services, regardless of whether the request arrived through an application programming interface, a portal, or a fax. A generic 'not medically necessary' response
without an identified unmet criterion should be challenged.
- Public reporting. Impacted payers must publicly report certain prior authorization metrics, which gives practices an external reference point when negotiating or escalating.
- Application programming interfaces. Impacted payers must implement Patient Access, Provider Access, Payer-to-Payer, and Prior Authorization interfaces generally by January 1, 2027, with compliance dates varying by payer type. Practices should be planning their own capability to consume those interfaces rather than waiting.
- State utilization review law. State statutes increasingly impose timelines, clinical peer requirements, criteria transparency obligations, and restrictions on algorithmic denial. These apply to state-regulated products and frequently exceed federal minimums.
Artificial Intelligence and Utilization Review
Payer use of AI in utilization review
CMS has permitted Medicare Advantage plans to use artificial intelligence to assist prior authorization determinations while requiring that the tools account for the beneficiary's individual clinical circumstances and the treating physician's recommendations, and that they not rely on datasets that fail to account for the individual's specific medical circumstances. In parallel, CMS itself introduced technology-assisted review into Original Medicare through the WISeR Model, in which model participants perform medical necessity review assisted by technology including artificial intelligence and machine learning.
The more consequential development, however, is at the state level. Legislatures have enacted a rapidly growing body of law restricting how insurers may use artificial intelligence in coverage determinations. The common architecture across these statutes is consistent even where the details differ.
- A licensed clinician, not an algorithm, must make an adverse medical necessity determination. Several states now provide that artificial intelligence may not be the sole basis to deny, delay, or modify a service, and that a licensed physician or other qualified health professional must make the determination.
- Individualized review is required. Statutes commonly require that the human reviewer consider the requesting provider's recommendation, the enrollee's medical or clinical history, and the enrollee's individual clinical circumstances, rather than relying on group-level datasets.
- Disclosure and transparency obligations attach. Several states require insurers to disclose their use of artificial intelligence in utilization review policies and procedures, and in some cases to enrollees and providers directly.
- Certification, audit, and non-discrimination requirements are emerging. Certain statutes require annual certification to the state regulator that the tool does not rely on a group dataset, is applied fairly, and does not discriminate, and subject the tool to regulatory inspection.
- Initial review versus adverse determination is a recurring distinction. Some states expressly permit AI-assisted initial review while prohibiting AI-issued adverse determinations, which means the practical question in an appeal is not whether AI was used but at which step it was used.
Frequently Asked Questions
The answers below are operational guidance and are not coverage determinations. Verify payer-specific positions against the current applicable policy.
Can we require the payer to tell us which criterion was unmet?
For impacted payers, operational provisions effective January 1, 2026 require a specific reason for a denied prior authorization for non-drug services regardless of how the request was submitted. Beyond that, state utilization review statutes frequently require criteria transparency. Ask for the guideline name, number, and version and the specific unmet criterion as a standing element of every appeal.
How fast must a payer decide?
For impacted payers under the CMS Interoperability and Prior Authorization final rule, expedited decisions are due within 72 hours and standard decisions within 7 calendar days, effective January 1, 2026. State law may impose shorter timelines for state-regulated products. Know both, and cite the shorter one.
Can a payer deny our request using artificial intelligence?
The answer is increasingly jurisdiction-specific. A growing number of states now require that an adverse medical necessity determination be made by a licensed physician or other qualified health professional and prohibit artificial intelligence from serving as the sole basis to deny, delay, or modify a service. Several also impose disclosure, individualized-review, certification, and audit requirements. Verify the statute and effective date for each state in which you operate, and ask on the record whether an automated tool contributed to the determination and at which step.
Authoritative References
Coverage policies, code sets, model parameters, and utilization management criteria change. Verify currency at the time of use.
- HHS Office of Inspector General Compliance Guidance: https://oig.hhs.gov/compliance/
- HHS Office of Inspector General Work Plan: https://oig.hhs.gov/reports-and-publications/workplan/
- CMS Interoperability and Prior Authorization Final Rule: https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-prior-authorization-final-rule-cms-0057-f
- CMS Medicare Coverage Database: https://www.cms.gov/medicare-coverage-database
- CMS WISeR Model: https://www.cms.gov/priorities/innovation/innovation-models/wiser
Related Orthopedic Pages
Orthopedic Coding and Billing Fundamentals
CPT families, diagnosis coding, modifiers, place of service, and coding risk.
Open this page →AI Governance in Orthopedic Practices
AI use cases, governance requirements, payer-side AI, and human accountability.
Open this page →Orthopedic Prior Authorization
Decision pathways, payer criteria, authorization workflow, peer-to-peer, and appeals.
Open this page →Strengthen Orthopedic Operations
GoHealthcare Practice Solutions supports orthopedic and musculoskeletal organizations with prior authorization, medical necessity, payer intelligence, documentation improvement, revenue cycle performance, compliance, and workflow design.
Request Help